Ntrk2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
.infobox .infobox-gene
| Gene Symbol | NTRK2 |
|---|---|
| Gene Name | Neurotrophic Receptor Tyrosine Kinase 2 |
| Chromosome | 9q21.33 |
| NCBI Gene ID | 4915 |
| OMIM ID | 600456 |
| Ensembl ID | ENSG00000100567 |
| UniProt ID | Q16620 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, Obesity |
| --- | --- |
| Categories | Neurotrophin Signaling, Neuroprotection |
Neurotrophic Receptor Tyrosine Kinase 2 (NTRK2), also known as TrkB, is the primary receptor for Brain-Derived Neurotrophic Factor (BDNF) and other neurotrophins. NTRK2 plays critical roles in neuronal development, synaptic plasticity, and cognitive function throughout the life span. The receptor is widely expressed in the central and peripheral nervous systems, with particularly high levels in the cortex, hippocampus, and basal forebrain. Upon BDNF binding, NTRK2 undergoes dimerization and autophosphorylation, triggering downstream signaling cascades that regulate synaptic strength, dendritic spine morphology, and long-term potentiation (LTP). NTRK2 is implicated in numerous neurological disorders including Alzheimer's disease, Parkinson's disease, and neuropsychiatric conditions. Genetic variants in NTRK2 have been associated with autism spectrum disorder and Rett syndrome, highlighting its importance in social and cognitive function.
NTRK2 (TrkB) is the primary receptor for BDNF and NT-4/5. It plays crucial roles in neuronal survival, synaptic plasticity, learning, and memory. TrkB signaling is mediated through PI3K/AKT, MAPK/ERK, and PLCγ pathways. Dysregulated TrkB signaling is implicated in neurodegenerative diseases, mood disorders, and obesity. Alternative splicing produces truncated isoforms that act as dominant-negative regulators.
The NTRK2 gene is associated with several neurodegenerative and neurological disorders. Specific mutations cause distinct clinical phenotypes, and common variants may influence disease risk.
The study of Ntrk2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.